Indices: Inventory market replace: Nifty Pharma index falls 1.29%

NEW DELHI: The Nifty Pharma index closed on a detrimental word on Monday.

Shares of Ipca Laboratories Ltd.(up 6.72 per cent), Aurobindo Pharma Ltd.(up 0.99 per cent), Abbott India Ltd.(up 0.33 per cent) and Sanofi India Ltd.(up 0.01 per cent) ended the day as high gainers within the pack.

However, Laurus Labs Ltd.(down 9.61 per cent), GlaxoSmithKline Prescribed drugs Ltd.(down 4.02 per cent), Granules India Ltd.(down 3.52 per cent), Glenmark Prescribed drugs Ltd.(down 2.72 per cent) and Gland Pharma Ltd.(down 2.54 per cent) completed as the highest losers of the day.

The Nifty Pharma index closed 1.29 per cent down at 14911.65.

Benchmark NSE Nifty50 index ended down 260.9 factors at 19281.75, whereas the BSE Sensex stood down 825.74 factors at 64571.88.

Among the many 50 shares within the Nifty index, 2 ended within the inexperienced, whereas 48 closed within the pink.

Shares of YES Financial institution, Vodafone Concept, JP Energy, Suzlon Power and Reliance Energy have been among the many most traded shares on the NSE. Shares of Macpower CNC Machine, Zodiac Power, CreditAccess Grameen, BSE and Ipca Labs hit their contemporary 52-week highs in at this time’s commerce, whereas TCNS Clothes, SMS Lifesciences Ind, Gangotri Textual content, Medicamen Bio and Digjam L hit their contemporary 52-week lows.

(What’s transferring Sensex and Nifty Observe newest market information, inventory ideas and skilled recommendation on ETMarkets. Additionally, ETMarkets.com is now on Telegram. For quickest information alerts on monetary markets, funding methods and shares alerts, subscribe to our Telegram feeds.)

Obtain The Financial Instances Information App to get Day by day Market Updates & Reside Enterprise Information.

High Trending Shares: Sensex In the present day Reside, SBI Share Value, Axis Financial institution Share Value, HDFC Financial institution Share Value, Infosys Share Value, Wipro Share Value, NTPC Share Value

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button